Testing effectiveness (Phase 2)Study completedNCT00458523
What this trial is testing
Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission
Who this might be right for
Leukemia
Leeds Cancer Centre at St. James's University Hospital 54